Organizing Committee Members - World pharma 2021
Moscow State University
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors.
Sergey Suchkov(Research Area)
Dr Suchkov has been collaborating with scientists from USA, Japan, Germany, Israel and other countries to set up a new brand in the modern medicine, i.e., PPPM. In 1991-1998, Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collaboration in the field of ocular immunology between Russian Academy of Sciences and National Institutes of Health (NIH); in 1991-1995 ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology.
University of Mississippi
University of British Columbia
Thomas Sanderson obtained his PhD at the age of 27 from the University of British Columbia, Vancouver, Canada and did postdoctoral studies at Michigan State University, USA. He is an associate professor at the INRS-Institut Armand-Frappier, Laval (QuÃƒÆ’Ã‚Â©bec), Canada and has published more than 70 papers in reputed journals. His toxicology laboratory is focused on studying interactions of chemicals with steroidogenic enzymes in humans and wildlife and is currently funded by the Natural Sciences and Engineering Council (NSERC) of Canada and the Alternatives Research and Development Foundation (USA). Thomas is editorial board member of Toxicological Sciences and PeerJ.
Thomas Sanderson(Research Area)
Development and application of physiologically relevant in vitro models of human steroidogenesis in toxicology: the endocrine disrupting potential of neonicotinoid pesticides in humans
CEO / Board Member
Yavuz Selim Silay(Biography)
Dr. Yavuz Selim SILAY graduated from Ankara in 2000 and worked as an academic and research director at the Baylor College of Medicine in Houston, Texas for 5 years. MD Anderson participated in the Physician Scientist training program, which was subsidized by the American National Institute of Health (NIH) in the Cancer Center. After successfully transitioning from academia to industry, Washington University, which was chosen as the second best Executive MBA of America by Wall Street Journal in 2010, received a master's degree in Olin Business School and received strategy, marketing, business, and leadership education until 2013. in industries as a top-level administrative decision to return to after receiving calÃ„Â±Ã…Å¸tÃ„Â±.tÃƒÂ¼rkiye ICG (Istanbul consulting Group) made on behalf of the world Bank under the project TC consulting the Ministry of Health.Turkey's first and only BstBI approved R & D center, which hospital hunters were prepared by the Department of yÃƒÂ¼rÃƒÂ¼ttÃƒÂ¼.Rutgers University Innovation and Education Department in danÃ„Â±Ã…Å¸mandÃ„Â±r.Istanbul AydÃ„Â±n University Health Incubation Center bio cube May 15 to 2018t organization infrastructure Hospital R & D center.
Yavuz Selim Silay(Research Area)
For 14 years, Dr. Yavuz Selim SILAY worked as the director of R&D, medical affairs, clinical research, and vice president of North America in many international pharmaceutical companies such as Forest Research Institute, Ipsen, Teva North America Branded Pharmaceuticals, Teva Neuroscience, VK / Ther-Rx / Ethex Pharmaceuticals in the United States, and rose to company presidency.